329 related articles for article (PubMed ID: 25369863)
1. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.
Handa H; Kuroda Y; Kimura K; Masuda Y; Hattori H; Alkebsi L; Matsumoto M; Kasamatsu T; Kobayashi N; Tahara KI; Takizawa M; Koiso H; Ishizaki T; Shimizu H; Yokohama A; Tsukamoto N; Saito T; Murakami H
Br J Haematol; 2017 Nov; 179(3):449-460. PubMed ID: 28770558
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.
Sedlarikova L; Gromesova B; Kubaczkova V; Radova L; Filipova J; Jarkovsky J; Brozova L; Velichova R; Almasi M; Penka M; Bezdekova R; Stork M; Adam Z; Pour L; Krejci M; Kuglík P; Hajek R; Sevcikova S
Eur J Haematol; 2017 Sep; 99(3):223-233. PubMed ID: 28543758
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.
Liu H; Wang H; Wu B; Yao K; Liao A; Miao M; Li Y; Yang W
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1032-1041. PubMed ID: 28664617
[TBL] [Abstract][Full Text] [Related]
10. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
Tian X; Xu G
BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
[TBL] [Abstract][Full Text] [Related]
13. Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.
Ronchetti D; Agnelli L; Taiana E; Galletti S; Manzoni M; Todoerti K; Musto P; Strozzi F; Neri A
Oncotarget; 2016 Mar; 7(12):14814-30. PubMed ID: 26895470
[TBL] [Abstract][Full Text] [Related]
14. Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma.
Li B; Chen P; Qu J; Shi L; Zhuang W; Fu J; Li J; Zhang X; Sun Y; Zhuang W
J Biol Chem; 2014 Oct; 289(42):29365-75. PubMed ID: 25187517
[TBL] [Abstract][Full Text] [Related]
15. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
Huang C; Yu Z; Yang H; Lin Y
Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
Yu H; Peng S; Chen X; Han S; Luo J
J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells.
Xiang J; Guo S; Jiang S; Xu Y; Li J; Li L; Xiang J
J Korean Med Sci; 2016 May; 31(5):688-94. PubMed ID: 27134488
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
[TBL] [Abstract][Full Text] [Related]
20. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ
Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
